2020-2022 年澳大利亚精神和药物并发症:普通人群中的患病率、模式、条件概率和相关因素。

IF 4 2区 医学 Q1 PSYCHIATRY Australian and New Zealand Journal of Psychiatry Pub Date : 2024-10-11 DOI:10.1177/00048674241284913
Matthew Sunderland, Joshua Vescovi, Cath Chapman, Vikas Arya, Meredith Harris, Philip Burgess, Christina Marel, Katherine Mills, Andrew Baillie, Maree Teesson, Tim Slade
{"title":"2020-2022 年澳大利亚精神和药物并发症:普通人群中的患病率、模式、条件概率和相关因素。","authors":"Matthew Sunderland, Joshua Vescovi, Cath Chapman, Vikas Arya, Meredith Harris, Philip Burgess, Christina Marel, Katherine Mills, Andrew Baillie, Maree Teesson, Tim Slade","doi":"10.1177/00048674241284913","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Previous estimates from 2007 found that co-occurring mental and/or substance use disorders were a pervasive feature of Australia's mental health. Since that time there have been shifts and improvements in the conceptualisation and incorporation of co-occurring disorders in research and treatment settings. The current study provides up-to-date estimates on the prevalence of co-occurring mental and/or substance use disorders, highlights common patterns of co-occurrence, identifies significant correlates and examines any changes in the extent of co-occurring disorders since 2007.</p><p><strong>Methods: </strong>Data were from the two Australian National Surveys of Mental Health and Wellbeing conducted in 2020-2022 (<i>N</i> = 15,893) and 2007 (<i>N</i> = 8841). Descriptive statistics were estimated for the number of co-occurring conditions, correlations and pairwise conditional probabilities. Multinomial logistic and robust Poisson regressions were used to identify significant correlates and compare changes in co-occurring conditions across surveys.</p><p><strong>Results: </strong>Approximately 46% of people with a mental or substance use disorder in the past 12 months experienced two or more diagnosable conditions. There was little evidence to suggest that the prevalence of co-occurring disorders has changed since 2007 (Prevalence Ratio (PR) = 1.08, 95% CI = 0.98-1.18). Subgroup analysis indicated that those aged 16-24 years were significantly more likely to experience any co-occurrence in 2020-2022 compared with those aged 16-24 years in 2007 (PR = 1.44, 95% CI = 1.17-1.77).</p><p><strong>Conclusions: </strong>Co-occurring mental and substance use disorders remain endemic in Australia. Indeed, they appear to be increasingly problematic in younger, more recent cohorts. The results suggest that continued effort is needed to develop and implement transdiagnostic interventions that target broad contextual and/or societal factors.</p>","PeriodicalId":8589,"journal":{"name":"Australian and New Zealand Journal of Psychiatry","volume":" ","pages":"48674241284913"},"PeriodicalIF":4.0000,"publicationDate":"2024-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Co-occurring mental and substance use disorders in Australia 2020-2022: Prevalence, patterns, conditional probabilities and correlates in the general population.\",\"authors\":\"Matthew Sunderland, Joshua Vescovi, Cath Chapman, Vikas Arya, Meredith Harris, Philip Burgess, Christina Marel, Katherine Mills, Andrew Baillie, Maree Teesson, Tim Slade\",\"doi\":\"10.1177/00048674241284913\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Previous estimates from 2007 found that co-occurring mental and/or substance use disorders were a pervasive feature of Australia's mental health. Since that time there have been shifts and improvements in the conceptualisation and incorporation of co-occurring disorders in research and treatment settings. The current study provides up-to-date estimates on the prevalence of co-occurring mental and/or substance use disorders, highlights common patterns of co-occurrence, identifies significant correlates and examines any changes in the extent of co-occurring disorders since 2007.</p><p><strong>Methods: </strong>Data were from the two Australian National Surveys of Mental Health and Wellbeing conducted in 2020-2022 (<i>N</i> = 15,893) and 2007 (<i>N</i> = 8841). Descriptive statistics were estimated for the number of co-occurring conditions, correlations and pairwise conditional probabilities. Multinomial logistic and robust Poisson regressions were used to identify significant correlates and compare changes in co-occurring conditions across surveys.</p><p><strong>Results: </strong>Approximately 46% of people with a mental or substance use disorder in the past 12 months experienced two or more diagnosable conditions. There was little evidence to suggest that the prevalence of co-occurring disorders has changed since 2007 (Prevalence Ratio (PR) = 1.08, 95% CI = 0.98-1.18). Subgroup analysis indicated that those aged 16-24 years were significantly more likely to experience any co-occurrence in 2020-2022 compared with those aged 16-24 years in 2007 (PR = 1.44, 95% CI = 1.17-1.77).</p><p><strong>Conclusions: </strong>Co-occurring mental and substance use disorders remain endemic in Australia. Indeed, they appear to be increasingly problematic in younger, more recent cohorts. The results suggest that continued effort is needed to develop and implement transdiagnostic interventions that target broad contextual and/or societal factors.</p>\",\"PeriodicalId\":8589,\"journal\":{\"name\":\"Australian and New Zealand Journal of Psychiatry\",\"volume\":\" \",\"pages\":\"48674241284913\"},\"PeriodicalIF\":4.0000,\"publicationDate\":\"2024-10-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Australian and New Zealand Journal of Psychiatry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/00048674241284913\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Australian and New Zealand Journal of Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/00048674241284913","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

摘要

背景:根据 2007 年的估算,精神和/或药物滥用并发症是澳大利亚精神健康的一个普遍特征。从那时起,在研究和治疗环境中对共存障碍的概念化和纳入方面发生了转变和改进。目前的研究提供了对精神和/或药物使用共存障碍患病率的最新估计,强调了共存障碍的常见模式,确定了重要的相关因素,并研究了自2007年以来共存障碍程度的任何变化:数据来自 2020-2022 年(样本数 = 15,893 人)和 2007 年(样本数 = 8841 人)进行的两次澳大利亚全国心理健康和福祉调查。对共存病症的数量、相关性和成对条件概率进行了描述性统计。使用多项式逻辑回归和稳健泊松回归来确定重要的相关因素,并比较不同调查中共存病症的变化:结果:在过去 12 个月中,约 46% 的精神或药物使用失调患者出现过两种或两种以上的可诊断病症。几乎没有证据表明,自 2007 年以来,并发症的患病率发生了变化(患病率比值 (PR) = 1.08,95% CI = 0.98-1.18)。分组分析表明,与 2007 年的 16-24 岁人群相比,2020-2022 年的 16-24 岁人群更有可能出现任何共患疾病(PR = 1.44,95% CI = 1.17-1.77):结论:在澳大利亚,精神疾病和药物滥用疾病并发的现象仍然普遍存在。结论:精神疾病和药物滥用并发症在澳大利亚仍然很普遍,事实上,在更年轻、更新近的人群中,问题似乎越来越严重。研究结果表明,需要继续努力开发和实施针对广泛背景和/或社会因素的跨诊断干预措施。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Co-occurring mental and substance use disorders in Australia 2020-2022: Prevalence, patterns, conditional probabilities and correlates in the general population.

Background: Previous estimates from 2007 found that co-occurring mental and/or substance use disorders were a pervasive feature of Australia's mental health. Since that time there have been shifts and improvements in the conceptualisation and incorporation of co-occurring disorders in research and treatment settings. The current study provides up-to-date estimates on the prevalence of co-occurring mental and/or substance use disorders, highlights common patterns of co-occurrence, identifies significant correlates and examines any changes in the extent of co-occurring disorders since 2007.

Methods: Data were from the two Australian National Surveys of Mental Health and Wellbeing conducted in 2020-2022 (N = 15,893) and 2007 (N = 8841). Descriptive statistics were estimated for the number of co-occurring conditions, correlations and pairwise conditional probabilities. Multinomial logistic and robust Poisson regressions were used to identify significant correlates and compare changes in co-occurring conditions across surveys.

Results: Approximately 46% of people with a mental or substance use disorder in the past 12 months experienced two or more diagnosable conditions. There was little evidence to suggest that the prevalence of co-occurring disorders has changed since 2007 (Prevalence Ratio (PR) = 1.08, 95% CI = 0.98-1.18). Subgroup analysis indicated that those aged 16-24 years were significantly more likely to experience any co-occurrence in 2020-2022 compared with those aged 16-24 years in 2007 (PR = 1.44, 95% CI = 1.17-1.77).

Conclusions: Co-occurring mental and substance use disorders remain endemic in Australia. Indeed, they appear to be increasingly problematic in younger, more recent cohorts. The results suggest that continued effort is needed to develop and implement transdiagnostic interventions that target broad contextual and/or societal factors.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
8.00
自引率
2.20%
发文量
149
审稿时长
6-12 weeks
期刊介绍: Australian & New Zealand Journal of Psychiatry is the official Journal of The Royal Australian and New Zealand College of Psychiatrists (RANZCP). The Australian & New Zealand Journal of Psychiatry is a monthly journal publishing original articles which describe research or report opinions of interest to psychiatrists. These contributions may be presented as original research, reviews, perspectives, commentaries and letters to the editor. The Australian & New Zealand Journal of Psychiatry is the leading psychiatry journal of the Asia-Pacific region.
期刊最新文献
Self-poisoning in young Australians: The impact of COVID-19 and recent trends following easing of restrictions. Letters to the Editor: Differential effects of access restriction to a highway bridge on suicide numbers by jumping. Extending the reach of involuntary treatment to substance use disorders: Is it 'compassionate' or coercive care? Policy implications of the 2020-22 Australian study of mental health and wellbeing. Glutamatergic neurotransmission in schizophrenia: A systematic review and quantitative synthesis of proton magnetic resonance spectroscopy studies across schizophrenia spectrum disorders.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1